Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Lilly To Start Phase III Trials in Diabetic Peripheral Neuropathy For LY-333531

Jun 17 2002

• By The Pink Sheet

Related Content

Lilly Forteo "Approvable": Indications, Manufacturing Issues To Be Resolved

Oct 08 2001

Lilly GMP “Culture Change” Will Address Compliance Issues, Firm Tells FDA

Feb 04 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window